Altered distribution of mGlu2 receptors in β-amyloid-affected brain regions of Alzheimer cases and aged PS2APP mice

[1]  G. Marek,et al.  In Vitro and in Vivo Evidence for a Lack of Interaction with Dopamine D2 Receptors by the Metabotropic Glutamate 2/3 Receptor Agonists 1S,2S,5R,6S-2-Aminobicyclo[3.1.0]hexane-2,6-bicaroxylate Monohydrate (LY354740) and (−)-2-Oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic Acid (LY379268) , 2009, Journal of Pharmacology and Experimental Therapeutics.

[2]  A. Delacourte,et al.  Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease , 2008, Neurobiology of Aging.

[3]  D. Riddle,et al.  Effects of aging and caloric restriction on dentate gyrus synapses and glutamate receptor subunits , 2008, Neurobiology of Aging.

[4]  J. Erickson,et al.  Efficacy and Tolerability of an mGlu2/3 Agonist in the Treatment of Generalized Anxiety Disorder , 2008, Neuropsychopharmacology.

[5]  C. Mulle,et al.  Presynaptic glutamate receptors: physiological functions and mechanisms of action , 2008, Nature Reviews Neuroscience.

[6]  Paul J. Harrison,et al.  Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia , 2008, Journal of psychopharmacology.

[7]  D. Lorrain,et al.  Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition , 2008, Brain Research.

[8]  J. Kemp,et al.  Asymmetric Synthesis and Receptor Pharmacology of the Group II mGlu Receptor Ligand (1S,2R,3R,5R,6S)‐2‐Amino‐3‐hydroxy‐bicyclo[3.1.0]hexane‐2,6‐dicarboxylic Acid—HYDIA , 2008, ChemMedChem.

[9]  D. Holtzman,et al.  Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.

[10]  P. Seeman,et al.  Dopamine partial agonist actions of the glutamate receptor agonists LY 354,740 and LY 379,268 , 2008, Synapse.

[11]  M. Weiner,et al.  Reduced hippocampal functional connectivity in Alzheimer disease. , 2007, Archives of neurology.

[12]  S. Mosolov,et al.  Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial , 2007, Nature Medicine.

[13]  F. Nicoletti,et al.  Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication? , 2007, Molecular Psychiatry.

[14]  Z. Xiang,et al.  A Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 2 Blocks a Hallucinogenic Drug Model of Psychosis , 2007, Molecular Pharmacology.

[15]  F. Nicoletti,et al.  The Use of Knock-Out Mice Unravels Distinct Roles for mGlu2 and mGlu3 Metabotropic Glutamate Receptors in Mechanisms of Neurodegeneration/Neuroprotection , 2007, The Journal of Neuroscience.

[16]  J. Trojanowski,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[17]  J. Gilley,et al.  Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connection. , 2007, Trends in molecular medicine.

[18]  Michael P. Coleman,et al.  Neuronal death: where does the end begin? , 2007, Trends in Neurosciences.

[19]  G. Marek,et al.  Metabotropic glutamate receptors in the control of mood disorders. , 2007, CNS & neurological disorders drug targets.

[20]  R. Mayeux,et al.  Hippocampal and entorhinal atrophy in mild cognitive impairment , 2007, Neurology.

[21]  H. Kretzschmar,et al.  Mutant Presenilin 1 Alters Synaptic Transmission in Cultured Hippocampal Neurons* , 2007, Journal of Biological Chemistry.

[22]  J. Csernansky,et al.  Spatial relationship between synapse loss and β‐amyloid deposition in Tg2576 mice , 2007, The Journal of comparative neurology.

[23]  R. Malinow,et al.  AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss , 2006, Neuron.

[24]  D. Bennett,et al.  The amyloid pathology progresses in a neurotransmitter-specific manner , 2006, Neurobiology of Aging.

[25]  Vince D. Calhoun,et al.  Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer's Disease: An Independent Component Analysis , 2006, The Journal of Neuroscience.

[26]  J. Witkin,et al.  Antagonism of metabotropic glutamate group II receptors in the potential treatment of neurological and neuropsychiatric disorders , 2006 .

[27]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[28]  D. Schoepp,et al.  Effects of mGlu2 or mGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: Specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus , 2006, Neuropharmacology.

[29]  J. Götz,et al.  Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? , 2006, Journal of neurochemistry.

[30]  M. Esiri,et al.  Down‐regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease , 2006, Journal of neurochemistry.

[31]  Francesco Ferraguti,et al.  Metabotropic glutamate receptors , 2006, Cell and Tissue Research.

[32]  H. Kretzschmar,et al.  Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein , 2006, The Journal of Neuroscience.

[33]  Mark Bowlby,et al.  Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Kemp,et al.  Glutamate- and GABA-based CNS therapeutics. , 2006, Current opinion in pharmacology.

[35]  C. J. Rivara,et al.  Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease , 2006, Neurobiology of Aging.

[36]  D. Peterson,et al.  Expression of a Familial Alzheimer's Disease-Linked Presenilin-1 Variant Enhances Perforant Pathway Lesion-Induced Neuronal Loss in the Entorhinal Cortex , 2006, The Journal of Neuroscience.

[37]  I. Ferrer,et al.  Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes , 2005, Neurobiology of Disease.

[38]  P. Greengard,et al.  Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses , 2005, Neurobiology of Disease.

[39]  S. Nakanishi,et al.  Opposite effects of Zn on the in vitro binding of [3H]LY354740 to recombinant and native metabotropic glutamate 2 and 3 receptors , 2005, Journal of neurochemistry.

[40]  Á. Simonyi,et al.  Expression of groups I and II metabotropic glutamate receptors in the rat brain during aging , 2005, Brain Research.

[41]  J. Kemp,et al.  Ionotropic and metabotropic glutamate receptor structure and pharmacology , 2005, Psychopharmacology.

[42]  E. Nisenbaum,et al.  Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s) , 2005, Psychopharmacology.

[43]  I. Feinberg,et al.  The Metabotropic Glutamate (mGLU)2/3 Receptor Antagonist LY341495 [2S-2-Amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic Acid] Stimulates Waking and Fast Electroencephalogram Power and Blocks the Effects of the mGLU2/3 Receptor Agonist LY379268 [(-)-2-Oxa-4-aminobicyclo[3.1.0]hexane , 2005, Journal of Pharmacology and Experimental Therapeutics.

[44]  C. Swanson,et al.  Metabotropic glutamate receptors as novel targets for anxiety and stress disorders , 2005, Nature Reviews Drug Discovery.

[45]  B. Bohrmann,et al.  Quantification of the A beta peptide in Alzheimer's plaques by laser dissection microscopy combined with mass spectrometry. , 2005, Journal of mass spectrometry : JMS.

[46]  J. Feldon,et al.  Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys , 2005, Psychopharmacology.

[47]  J. Kew,et al.  Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential. , 2004, Pharmacology & therapeutics.

[48]  J. Morrison,et al.  The aging brain: morphomolecular senescence of cortical circuits , 2004, Trends in Neurosciences.

[49]  S. Gandy,et al.  Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage , 2004, Experimental Neurology.

[50]  S. Nakanishi,et al.  Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent , 2004, Neuropharmacology.

[51]  Hyoung-Gon Lee,et al.  Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer’s disease , 2004, Acta Neuropathologica.

[52]  R. Shigemoto,et al.  Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology , 2003, Neuroscience Letters.

[53]  J. Kemp,et al.  PS2APP Transgenic Mice, Coexpressing hPS2mut and hAPPswe, Show Age-Related Cognitive Deficits Associated with Discrete Brain Amyloid Deposition and Inflammation , 2003, The Journal of Neuroscience.

[54]  M. Amalric,et al.  Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders , 2003, Behavioural pharmacology.

[55]  Amanda M Li,et al.  Reduced synaptic plasticity in the lateral perforant path input to the dentate gyrus of aged C57BL/6 mice. , 2003, Journal of neurophysiology.

[56]  L. Levine,et al.  LY354740, an mGlu2/3 Receptor Agonist as a Novel Approach to Treat Anxiety/Stress , 2003, Stress.

[57]  D. Peterson,et al.  Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice , 2002, The Journal of Neuroscience.

[58]  M. Cuzner,et al.  Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up‐regulated in Alzheimer's disease , 2002, Journal of neurochemistry.

[59]  J. Kemp,et al.  Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 -/- mice , 2002, Neuropharmacology.

[60]  J. Kemp,et al.  Activity-dependent presynaptic autoinhibition by group II metabotropic glutamate receptors at the perforant path inputs to the dentate gyrus and CA1 , 2001, Neuropharmacology.

[61]  D. Schoepp.  Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. , 2001, The Journal of pharmacology and experimental therapeutics.

[62]  R. Shigemoto,et al.  Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites , 2001, Neuroscience.

[63]  F. Nicoletti,et al.  Metabotropic Glutamate Receptor Subtypes as Targets for Neuroprotective Drugs , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[64]  P. Ornstein,et al.  [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain. , 2001, The Journal of pharmacology and experimental therapeutics.

[65]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[66]  J. Penney,et al.  Glutamate Receptor Dysregulation in the Hippocampus of Transgenic Mice Carrying Mutated Human Amyloid Precursor Protein , 2001, Neurobiology of Disease.

[67]  U. Rüb,et al.  Alzheimer-Related τ-Pathology in the Perforant Path Target Zone and in the Hippocampal Stratum Oriens and Radiatum Correlates with Onset and Degree of Dementia , 2000, Experimental Neurology.

[68]  S. Augood,et al.  LocaliZation of metabotropic glutamate receptor type 2 in the human brain , 1999, Neuroscience.

[69]  D. Jane,et al.  Pharmacological agents acting at subtypes of metabotropic glutamate receptors , 1999, Neuropharmacology.

[70]  P. Ornstein,et al.  [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells , 1999, Neuropharmacology.

[71]  R. Nicoll,et al.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J. Kemp,et al.  Characterization of (2S,2′R,3′R)‐2‐(2′,3′‐[3H]‐Dicarboxycyclopropyl)glycine Binding in Rat Brain , 1998, Journal of neurochemistry.

[73]  J. Buxbaum,et al.  Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path , 1998, The Journal of Neuroscience.

[74]  J. Kemp,et al.  In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain. , 1998, Molecular pharmacology.

[75]  N. Mizuno,et al.  Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody , 1998, Neuroscience Research.

[76]  E. Masliah,et al.  Alterations in glutamate receptor 2/3 subunits and amyloid precursor protein expression during the course of Alzheimer’s disease and Lewy body variant , 1997, Acta Neuropathologica.

[77]  Ayae Kinoshita,et al.  Differential Presynaptic Localization of Metabotropic Glutamate Receptor Subtypes in the Rat Hippocampus , 1997, The Journal of Neuroscience.

[78]  I. Blümcke,et al.  Immunohistochemical distribution of metabotropic glutamate receptor subtypes mGluR1b, mGluR2/3, mGluR4a and mGluR5 in human hippocampus , 1996, Brain Research.

[79]  S. Nakanishi,et al.  Impairment of Hippocampal Mossy Fiber LTD in Mice Lacking mGluR2 , 1996, Science.

[80]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[81]  R. Petralia,et al.  The metabotropic glutamate receptors, MGLUR2 and MGLUR3, show unique postsynaptic, presynaptic and glial localizations , 1996, Neuroscience.

[82]  T. Kaneko,et al.  Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody , 1996, Neuroscience Letters.

[83]  J. Penney,et al.  Glutamate receptor expression in rat striatum: Effect of deafferentation , 1994, Brain Research.

[84]  J. Penney,et al.  Differential expression of metabotropic glutamate receptors in the hippocampus and entorhinal cortex of the rat. , 1994, Brain research. Molecular brain research.

[85]  H. Vinters,et al.  Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[86]  D. Graham,et al.  Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus , 1991, Brain Research.

[87]  R. Faull,et al.  Alzheimer's disease: Changes in hippocampal N-methyl-d-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors—an autoradiographic study , 1990, Neuroscience.

[88]  J. Penney,et al.  Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[89]  A. Young,et al.  Excitatory amino acids and Alzheimer's disease , 1989, Neurobiology of Aging.

[90]  G. V. Van Hoesen,et al.  Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease , 1987, Annals of neurology.

[91]  P. Seeman,et al.  Short Communication Glutamate Receptor mGlu2 and mGlu3 Knockout Striata are Dopamine Supersensitive, With Elevated D2 High Receptors and Marked Supersensitivity to the Dopamine Agonist (1)PHNO , 2009 .

[92]  P. Malherbe,et al.  Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTPgammas binding. , 2005, The Journal of comparative neurology.

[93]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[94]  P. Ornstein,et al.  [H]LY341495 Binding to Group II Metabotropic Glutamate Receptors in Rat Brain , 2001 .

[95]  G. Paxinos,et al.  Atlas of the Human Brain , 2000 .

[96]  S. Nakanishi,et al.  349 Distribution of the mRNA for a metabotropic glutamate receptor, mGluR4, in the rat central nervous system , 1993 .

[97]  Douglas L. Rosene,et al.  The Hippocampal Formation of the Primate Brain , 1987 .

[98]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .